| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.36 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |